609 Results

People

  1. Lilja
    Lilja
  2. Vickers
    Vickers
  3. Scher
    Scher
  4. Eastham
    Eastham
  5. Scardino
    Scardino
  6. Zelefsky
    Zelefsky
  7. Kattan
    Kattan
  8. Carlsson
    Carlsson
  9. Kelly
    Kelly
  10. Slovin
    Slovin

Groups

  1. Surgery (295)
  2. Urology (293)
  3. Population Sciences Research Program (215)
  4. Epidemiology and Biostatistics (178)
  5. Sloan Kettering Institute Faculty (171)
  6. Molecular Pharmacology and Chemistry Program Faculty (168)
  7. Department of Medicine (143)
  8. Solid Tumor Oncology Division (138)
  9. Genitourinary Oncology Service (135)
  10. Health Outcomes Research Group (133)
  1. "prostate-specific antigen"
Formats
  1. Journal Article (570)
  2. Editorial (8)
  3. Review (8)
  4. Conference Paper (6)
  5. Guidelines (5)
  6. Meeting Abstract (4)
  7. Book Section (3)
  8. Correspondence (3)
  9. Research Letter (2)
Groups
  1. Surgery (295)
  2. Urology (293)
  3. Population Sciences Research Program (215)
  4. Epidemiology and Biostatistics (178)
  5. Sloan Kettering Institute Faculty (171)
  6. Molecular Pharmacology and Chemistry Program Faculty (168)

More Groups

People
  1. Hans Lilja (135)
  2. Peter Scardino (117)
  3. Andrew Vickers (98)
  4. Howard Scher (96)
  5. James Eastham (80)
  6. Michael Zelefsky (64)

More People

Years
  1. 2025 (3)
  2. 2024 (26)
  3. 2023 (28)
  4. 2022 (28)
  5. 2021 (8)
  6. 2020 (5)

More Years

Publications
  1. Journal of Urology (69)
  2. European Urology (47)
  3. International Journal of Radiation Oncology, Biology, Physics (40)
  4. Journal of Clinical Oncology (39)
  5. Urology (36)
  6. Clinical Cancer Research (31)

More Publications

Publishers
  1. Elsevier Science, Inc. (162)
  2. Elsevier Inc. (72)
  3. Wiley Blackwell (64)
  4. American Association for Cancer Research (46)
  5. American Society of Clinical Oncology (39)
  6. John Wiley & Sons (29)

More Publishers

Results (609)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prostate adenocarcinoma grade group 1: Rationale for retaining a cancer label in the 2022 World Health Organization Classification
    Editorial

    Netto, G. J.; Amin, M. B.; Compérat, E. M.; Gill, A. J.; Hartmann, A.; Moch, H.; Menon, S.; Raspollini, M. R.; Rubin, M. A.; Srigley, J. R.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Addition of a genetic risk score for identification of men with a low prostate-specific antigen level in midlife at risk of developing lethal prostate cancer
    Correspondence

    Ma, C.; Ericsson, C.; Carlsson, S. V.; Lilja, H.; Kibel, A.; Graff, R. E.; Plym, A.; Giovannucci, E.; Mucci, L. A.; Preston, M. A.; more...
    European Urology Open Science (2023)

    Fulltext@MSK | Save
  • Oncologic outcomes of patients with lymph node invasion at prostatectomy and post-prostatectomy biochemical persistence
    Journal Article

    Perera, M.; Lebdai, S.; Tin, A. L.; Sjoberg, D. D.; Benfante, N.; Beech, B. B.; Alvim, R. G.; Touijer, A. S.; Jenjitranant, P.; Ehdaie, B.; more...
    Urologic Oncology: Seminars and Original Investigations (2023)

    Fulltext@MSK | Save
  • Introduction to a seminar on revisiting the value of PSA-based prostate cancer screening
    Review

    Carlsson, S. V.
    Urologic Oncology: Seminars and Original Investigations (2023)

    Fulltext@MSK | Save
  • Young age on starting prostate-specific antigen testing is associated with a greater reduction in prostate cancer mortality: 24-year follow-up of the Göteborg randomized population-based prostate cancer screening trial
    Journal Article

    Carlsson, S. V.; Arnsrud Godtman, R.; Pihl, C. G.; Vickers, A.; Lilja, H.; Hugosson, J.; Månsson, M.
    European Urology (2023)

    Fulltext@MSK | Save
  • Re: Adjuvant versus early salvage radiation therapy after radical prostatectomy for pN1 prostate cancer and the risk of death
    Correspondence

    Plata Bello, A.; Touijer, K.
    European Urology (2023)

    Fulltext@MSK | Save
  • Emergence of BRCA reversion mutations in patients with metastatic castration-resistant prostate cancer after treatment with rucaparib
    Journal Article

    Loehr, A.; Hussain, A.; Patnaik, A.; Bryce, A. H.; Castellano, D.; Font, A.; Shapiro, J.; Zhang, J.; Sautois, B.; Vogelzang, N. J.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Blood prostate-specific antigen by volume of benign, Gleason pattern 3 and 4 prostate tissue
    Journal Article

    Andolfi, C.; Vickers, A. J.; Cooperberg, M. R.; Carroll, P. R.; Cowan, J. E.; Paner, G. P.; Helfand, B. T.; Liauw, S. L.; Eggener, S. E.
    Urology (2022)

    Fulltext@MSK | Save
  • Failure patterns by PSMA PET for recurrent prostate cancer after prostatectomy and salvage radiation
    Journal Article

    Imber, B. S.; O'Dwyer, E.; Lobaugh, S.; McBride, S. M.; Hopkins, M.; Kollmeier, M.; Gorovets, D.; Brennan, V.; Pike, L. R. G.; Gewanter, R.; more...
    Urology (2022)

    Fulltext@MSK | Save
  • Advancing traditional prostate-specific antigen kinetics in the detection of prostate cancer: A machine learning model
    Journal Article

    Perera, M.; Smith, L.; Thompson, I.; Breemer, G.; Papa, N.; Patel, M. I.; Swindle, P.; Smith, E.
    European Urology Focus (2022)

    Fulltext@MSK | Save